Research Article: Virus-Like Particles Assembled Using Respiratory Syncytial Virus Matrix Protein Elicit Protective Immunity in Mice
Introduction:
Virus-like particles (VLPs), since their emergence into the scientific limelight, have become a highly sought platform for vaccine development. Because VLPs do not possess any genetic materials necessary for progeny virus production, these nanoparticles are incapable of replicating in host cells or causing infection. Numerous studies have identified various intrinsic properties contributing to their high immunogenicity such as their small size, surface charges promoting receptor interaction, and others. – Thus…
Read more